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Abstract
TrkA-mediated NGF signaling in PC12 cells has been shown to be compartimentalized in specialized microdomains
of the plasma membrane, the caveolae, which are organized by scaffold proteins including the member of the
caveolin family of proteins, caveolin-1. Here, we characterize the intracellular distribution as well as the biochemical
and functional properties of the neuroendocrine long coiled-coil protein 2 (NECC2), a novel long coiled-coil protein
selectively expressed in neuroendocrine tissues that contains a predicted caveolin-binding domain and displays
structural characteristics of a scaffolding factor. NECC2 distributes in caveolae, wherein it colocalizes with the TrkA
receptor, and behaves as a caveolae-associated protein in neuroendocrine PC12 cells. In addition, stimulation of
PC12 cells with nerve growth factor (NGF) increased the expression and regulated the distribution of NECC2.
Interestingly, knockdown as well as overexpression of NECC2 resulted in a reduction of NGF-induced
phosphorylation of the TrkA downstream effector extracellular signal-regulated kinases 1 and 2 (ERK1/ERK2) but not
of Akt. Altogether, our results identify NECC2 as a novel component of caveolae in PC12 cells and support the
contribution of this protein in the maintenance of TrkA-mediated NGF signaling.
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Introduction
Neuroendocrine long coiled-coil protein 2, also referred to as
Jakmip3, is the third and still uncharacterized member of a
family of long coiled-coil, vertebrate-specific proteins composed
of two additional members, Jakmip1/Marlin1 and NECC1/
Jakmip2. Jakmip1/Marlin1 is predominantly expressed in
neurons and lymphoid cells. In lymphocytes, Jakmip1
associates with microtubules and the non-receptor tyrosine
kinases Tyk2 and Jak1 and has been proposed to participate in
polarized secretion and segregation of signaling complexes [1].
Jakmip1/Marlin1 associates with microtubules and the
molecular motor kinesin-1 [2,3] in neurons, wherein it has been
suggested to play a role in the maintenance of the structural
organization of the Golgi apparatus and in cell morphogenesis
and migration [4]. Both Necc1 and its ortholog, Necc2, are
preferentially expressed in neuronal, neuroendocrine, and
endocrine tissues [5]. Specifically, NECC1 locates to the Golgi
apparatus in neuroendocrine PC12 cells and controls the
regulated release of secretory cargo [6].
Long coiled-coil proteins represent highly versatile molecules
that exert a wide variety of essential functions in eukaryotic
cells [7]. They serve as tethering factors controlling the
association of transport vesicles with target membranes as well
as membrane pairing and fusion events. Long coiled-coil
proteins have been also proposed to act as molecular scaffolds
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to maintain and organize intracellular compartments, including
the nuclear envelope, the Golgi apparatus or the presynaptic
active zone [7–11]. Given their ability to interact with multiple
partners, these proteins have been suggested to integrate
signals and transduction pathways [7]. Indeed, there is
compelling evidence supporting the relevance of scaffolding
factors in the organization of membrane microdomains
specialized in transmembrane signalling, such as caveolae
[12,13]. Caveolae are enriched in the integral membrane
protein caveolin-1, and constitute localized platforms for
downstream signaling of several tyrosine kinase receptors [14].
Specifically, the high affinity neurotrophin receptor TrkA, as
well as many of the intermediates involved in the TrkA
signaling cascade, have been shown to locate to caveolae or to
caveolae-like membranes in PC12 cells and in TrkA-
transfected NIH-3T3 cells [15,16]. Remarkably, the presence of
long coiled-coil proteins in caveolae has not been documented
yet.
Herein, we demonstrate that NECC2, whose expression and
localization in PC12 cells is regulated by nerve growth factor
(NGF), co-localizes with caveolin-1 and TrkA in the plasma
membrane of these cells. Moreover, we show that both
silencing and overexpression of Necc2 impairs TrkA-dependent
activation of extracellular-regulated kinases 1 and 2 (ERK1/
ERK2) without modifying TrkA-dependent Akt phosphorylation.
Taken together, our data indicate that NECC2 is a novel
component of caveolae in PC12 cells, and support a role for
this protein as a molecular scaffold modulating NGF-mediated
TrkA signal transduction.
Materials and Methods
Antibodies and reagents
Two polyclonal antisera, anti-NECC2-I and anti-NECC2-II,
were raised by rabbit immunization with synthetic peptides
corresponding to amino acid residues 2-17
(SKKGAGSRAKGDKAE) and 434-447 (RYRKQRKKMAKLPK)
of rat NECC2, respectively. Purified antibodies were obtained
by immunoaffinity chromatography with the corresponding
immobilized peptide. Monoclonal anti-cMyc antibody was
purchased from Serotec (Oxford, UK). Monoclonal antibodies
to GM130 and EEA1 were from BD Transduction Labs
(Lexington, KY). Rabbit polyclonal anti-TrkA antibody was from
Millipore (Billerica, MA) and mouse anti-γ-tubulin was from
Thermo Fisher Scientific Inc. (Waltham, MA). Mouse anti-
caveolin-1 was from Novus Biologicals (Cambridge, UK).
Polyclonal antibodies to Akt, pAkt (Ser473), and p44/42 MAPK
(T202/Y204) were from Cell Signaling Technology Inc.
(Danvers, MA). Polyclonal antibody to ERK1/2 was from Santa
Cruz Biotechnology (Heidelberg, Germany). Alexa Fluor-
conjugated secondary antibodies, and Lipofectamine 2000
were from Invitrogen (Carlsbad, CA). NGF 7S was purchased
from Chemicon (Temecula, CA). Latrunculin B was from
Calbiochem (Darmstadt, Germany). Unless otherwise
indicated, all other reagents were purchased from Sigma-
Aldrich (Madrid, Spain).
Computational analysis
Database search and prediction of alternatively spliced
isoforms were performed using GNOMON (http://
www.ncbi.nlm.nih.gov/projects/genome/guide/gnomon.shtml)
and Ensembl Genome Browser (http://www.ensembl.org)
websites. Analysis of amino acid sequences was carried out
using ScanProsite, MotifScan, and Pfam algorithms included in
the Expasy server (http://www.expasy.net/). Target regions for
siRNA were designed using algorithms available on Promega
website (http://www.promega.com/siRNADesigner/) and
chosen according to the guidelines for effective siRNAs [17].
Plasmid expression vectors and DNA constructs
Constructs encoding GFP-Necc2 and cMyc-Necc2 have
been previously described [5]. To generate plasmid vectors
containing truncated versions of NECC2, different fragments of
mouse Necc2 cDNA corresponding to amino acid residues
1-285 (Δ285), 1-372 (Δ372) or 1-825 (ΔCBD) fused to the C-
terminus of cMyc were amplified by PCR and subcloned into
pcDNA3 vector (Invitrogen). Untagged Necc2 cDNA was also
cloned into pcDNA3 vector. Plasmids coding for rat TrkA
tagged with HA epitope and Caveolin-1 were kindly provided by
Dr. J.X. Comella (Vall d’Hebron Research Institute, Barcelona,
Spain) and Dr. B. Chini (CNR Neuroscience Institute, Milan,
Italy), respectively. Caveolin-1 was subcloned in frame to the
C-terminus of CFP in the pECFP-C1 vector.
A specific siRNA for silencing rat Necc2 (5´-
GTTTGTGCAGTTGCTTTAT -3´) was cloned using the BglII
and HindIII sites in front of the H1- RNA promoter of the
pEGFP-RNAi plasmid as described earlier [18].
Cell culture and NGF treatment
PC12 cells derived from pheochromocytoma of rat adrenal
medulla [ATCC (CRL-172)] and HEK-293 AD cells derived from
human embryonic kidney 293 cells [ATCC (CRL-157)] were
grown to 90% confluence and exposed for 4 h to low-serum
differentiation media (DMEM containing 1% horse serum, 1%
antibiotic/antimycotic solution, and 2 mmol/L of L-glutamine).
Cells were then stimulated with NGF (0,76 mmol/L) for several
time intervals, as indicated. For differentiation experiments,
PC12 cells were seeded onto 25-mm poly L-lysine coated
glass coverslips (25.000 cells/coverslip) and incubated in
differentiation media containing 0,76 mmol/L of NGF for 4 days.
Transfection and selection of stably shRNA-plasmid
transfected PC12 cells
Transient transfection of cells was performed using
Lipofectamine 2000. Transfected cells were used for
experiments 24 h later. For short-term NGF treatments of cells
overexpressing NECC2, T25 flasks of transiently transfected-
PC12 cells were plated 1 day after transfection at a density of
100.000 cells onto 12-well plates. Cell viability was assessed
by MTT assay according to the manufacturer’s instructions. To
generate stably transfected cells, PC12 cells were transfected
with 1 µg of pEGFP-RNAi or pEGFP-RNAi-Necc2. Twenty-four
h later, transfected cells were selected with 1,4 µmol/L of
geneticin. Selection efficiency was tested by flow cytometry for
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GFP expression, which was detected in 51% of the transfected
cells
RNA isolation and expression analysis by RT-PCR
Total RNA from PC12 cells was isolated using RNA-easy
Mini Kit columns (Qiagen, Hilden, Germany), and a 2-µg aliquot
of total RNA was reverse transcribed with the cDNA First-
Strand Synthesis kit using random primers (Fermentas,
Hanover, MD). The cDNA was used as a template for standard
PCR amplification of rat Necc2 using specific primers (forward
5´-CGGAAGAAGAGCGTGAGAAG-3´; reverse 5´-
TCCCGTTAGAGGACAAAGGT-3´). Nested PCR was carried
out to amplify alternative spliced Necc2 isoforms using internal
reverse primers (5´-GACCAGAGAATGAAAGCTAGGG-3´; 5´-
TTCGCAGAGGGCTTTTCTTC-3´). Non-DNA controls were run
to control for exogenous contamination. PCR products were
purified (Bioneer Inc., CA), and sequenced (SCAI, University of
Córdoba) to confirm identities of amplicons.
Immunofluorescence and confocal microscopy
PC12 and HEK-293 AD cells grown on glass coverslips were
processed for immunofluorescence and examined by confocal
microscopy as described previously [6]. In a set of
experiments, cells were exposed to 5 µmol/L of Latrunculin B
(LatB) for 30 min and then processed for
immunocytochemistry. Deconvolution of confocal images was
carried out using the software package HUYGENS
ESSENTIAL 2.4.4 (Scientific Volume Imaging, Hilversum, The
Netherlands). Colocalization rates were determined by an
overlapping pixel map of the two fluorescent channels (i.e., a
mask) using the Colocalization Finder plugin for ImageJ 1.44
(NIH, Bethesda, MA) and Manders’ coefficient (MC) using
Imaris software (Bitplane, Zurich, Switzerland).
SDS-PAGE and immunoblotting
Whole-cell protein extracts were obtained by homogenization
in RIPA buffer containing protease inhibitors. NGF-stimulated
cells were lysed in SDS-dithiothreitol buffer [19]. 60 µg of total
protein in RIPA buffer or 20 µl of SDS-DTT cell lysate were
separated by SDS-PAGE and immunoblotted with specific
antibodies. Densitometric analysis of the immunoreactive
bands was carried out with ImageJ software. Quantitative data
obtained with the anti-pAkt or anti-p42/44 MAPK sera were
normalized against the corresponding total Akt or ERK values,
respectively.
Subcellular fractionation
Cytosolic (S) and crude membrane (P) fractions of PC12
cells were obtained by subcellular fractionation [6]. Protein
distribution was analyzed by immunoblotting using 50 µg of
protein of each fraction.
Detergent-free Cell Membrane Fractionation
Caveolin-enriched membrane fractions were isolated from
PC12 cells grown to confluency [15]. After ultracentrifugation, 9
fractions (450 µl) were collected from the top of the sucrose
gradient and subsequently analyzed by SDS-PAGE.
Statistical analysis
Data from PC12 cells were obtained from a minimum of
three independent experiments. Statistical analysis was
performed using GraphPad Prism 4 (GraphPad Software, Inc.,
La Jolla, CA, US). A one-way ANOVA followed by a statistical
test for multiple comparisons (Newman-Keuls Multiple
Comparison test) was applied to compare experimental
treatments. For the analysis of the effects of NGF on TrkA
signaling in the short-term, a Student’s t –test was used.
Differences were considered statistically significant if p < 0.05.
Data are expressed as mean ± S.E.M.
Results
Structural analysis of NECC2
The general features of the NECC2 sequence have been
already depicted [5]. Further characterization of the 19-amino
acid hydrophobic region (HR) region revealed the presence of
two overlapping caveolin-binding domains (CBD) [ØXØXXXXØ
(amino acids 829 to 836), and ØXØXXXXØXXØ (amino acids
833 to 843), X being any amino acid, and Ø an aromatic amino
acid (Trp, Phe, or Tyr)] [20] (Figure 1A).
NECC2 contains four predicted CRAC (cholesterol
recognition/interaction amino acid consensus) domains [21],
five dileucine motifs, which represent conventional signals for
endocytosis [22], one leucine zipper domain, three potential
tyrosine kinase phosphorylation sites, including one Akt- and
two ERK-specific phosphorylation sites [23], one N-
glycosylation site, and six N-myristoylation sites (Figure 1A).
NECC2 also contains seven diacidic DXE (Asp-X-Glu) motifs,
which mediate the export of proteins from the endoplasmic
reticulum [24], and two PXXP domains, which act as target
sequences for SH3-type domains [25].
Analysis of the genomic sequence of rat Necc2 allowed us to
identify a novel Necc2 gene variant. This variant would
originate by alternative intra-exonic splicing of exon 21, which
codes for most of the C-terminal HR (residues 825–843).
Alternatively spliced mRNAs would generate a short isoform of
844 amino acids containing the HR (98,7 kDa), and a 915
amino acids-isoform (106 kDa) containing an alternative C-
terminus (Figure 1B), which were indeed amplified using
specific RT-PCR primers flanking the HR (Figure 1C).
Specificity of the amplicons was assessed by PCR re-
amplification analysis using internal RT-PCR primers for each
transcript (nested PCR).
NECC2 is localized to caveolae in PC12 cells
Immunostaining of PC12 with a polyclonal antibody raised
against the N-terminal region of NECC2 (anti-NECC2) revealed
that NECC2 distributed diffusely throughout the cytoplasm and
in close apposition to the plasma membrane (Figure 2A).
Preadsorption of the anti-NECC2 antibody with its specific
antigen (10-6 M) resulted in no staining (Figure 2A). The ability
of the antibody to recognize NECC2 was confirmed in cMyc-
Necc2-transfected HEK-293 AD cells, which do not express
NECC2 endogenously (Figure S1A). Moreover, anti-NECC2
antibody did not recognize exogenous NECC1 (Figure S1A).
The anti-NECC2 antibody also labeled cell nuclei, although this
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Figure 1.  In silico analysis of rat NECC2 sequence.  A. Schematic representation of the structural and functional motifs predicted
in rat NECC2 amino acid sequence. B. Schematic representation of the genomic structure of rat Necc2 coding for the Necc2 isoform
containing the HR domain and a newly identified transcript lacking this domain (Necc2α). Arrows indicate the location of the paired
primers used to amplify both Necc2 transcripts. C. Standard PCR amplification in PC12 cells shows two PCR products with the
expected sizes for the two rat Necc2 transcripts (left panel; primers a and b). Nested PCR amplification of Necc2 transcript (central
panel; primer c) or the Necc2α transcript (rightmost panel; primer d) using specific internal reverse primers. Non-DNA samples (C-)
are shown as controls for exogenous contamination.
doi: 10.1371/journal.pone.0073668.g001
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immunosignal was not abolished after preadsorption of the
anti-NECC2 serum. A second polyclonal antibody raised
against the central region of NECC2 (anti-NECC2-II) confirmed
the localization of endogenous NECC2 at the cell surface in
PC12 cells (Figure S1B). Similarly, the ability of the anti-
NECC2-II antibody to specifically recognize NECC2 was
assessed in Necc2-transfected HEK-293 AD cells (Figure
S1C). The anti-NECC2-II antibody did not recognize
exogenous NECC1 in HEK-293 AD cells (Figure S1C).
Given the presence of two overlapping CBDs at the C-
terminus of NECC2, we carried out double
immunofluorescence in PC12 cells using antibodies against the
caveolae marker, caveolin-1, and the anti-NECC2 antibody.
Examination by confocal microscopy revealed a high degree of
overlap between NECC2 and caveolin-1 at the cell surface
(Figure 2B). Immunolabeling of NECC2 with the anti-NECC2-II
antibody also showed a high degree of colocalization between
NECC2 and caveolin-1 immunosignals (Figure S1B).
Moreover, NECC2 immunosignal also colocalized with cortical
actin (Figure 2B). Pretreatment of PC12 cells with LatB
significantly disrupted both cortical actin and caveolin-1
distribution at the plasma membrane. LatB treatment also
prevented NECC2 localization to the cell periphery, leading to a
loss of co-localization between NECC2 and caveolin-1 or actin
(Figure 2C).
In contrast to that found for the endogenous protein,
exogenous cMyc-tagged NECC2 accumulated in the
perinuclear region of PC12 cells (Figure S2A). These results
are reminiscent of that previously reported for the Necc2
ortholog, Necc1, which forms protein aggregates when
transfected in PC12 cells [6]. Likewise, we observed that
caveolin-1 accumulated close to the nucleus when
exogenously expressed in PC12 cells (Figure S2B), which is in
accordance with previous reports in COS-7 and U2OS cells
[26,27]. Analysis of PC12 cells co-transfected with cMyc-Necc2
and CFP-cav1 revealed the colocalization between the two
proteins (Figure 3B). We next analyzed the distribution pattern
of the deletion mutant of NECC2 lacking the HR domain
(NECC2ΔHR) (Figure 3A). As shown in Figure 3B, NECC2ΔHR
distributed at the cell surface, wherein it colocalized with
caveolin-1. Intracellular accumulation of both proteins was also
observed. A shorter truncated form of NECC2 (NECC2Δ372)
containing the first 4 N-terminal coiled-coil regions (Figure 3A)
also partially overlapped with caveolin-1 at the plasma
membrane (Figure 3B). Together, these results suggest that
the CBDs are not strictly required for localization of NECC2 to
caveolae.
NECC2 behaves as a caveolae membrane protein
Immunoblot analysis of protein extracts from PC12 cells
using the anti-NECC2 antibody revealed an immunoreactive
band of approximately 110 kDa (Figure 4A), which is close to
the expected molecular weight calculated from the cDNA of
full-length Necc2. Immunodetection was abolished after
preadsorption of the antibody with the purified antigen (Figure
4A), as well as in Necc2-shRNA (siRNA) transfected cells (see
below). The anti-NECC2 antibody strongly immunolabeled
exogenous NECC2 in cMyc-NECC2-transfected HEK-293 AD
cells, whereas it did not recognize exogenous NECC1 in cMyc-
NECC1-transfected cells (Figure S3A). Immunoblotting of
protein extracts from PC12 cells using the anti-NECC2-II
antibody revealed a similar 110-kDa band, along with two other
immunoreactive bands of 140 and 95 kDa (Figure S1D). The
NECC2-II antibody recognized exogenous full-length NECC2
but not NECC1 or the truncated form of NECC2 lacking the
peptide sequence employed to obtain this antibody,
NECC2Δ285 (Figure S3A–C).
To further characterize NECC2, we performed subcellular
fractionation studies. Immunoblot analysis of cytosolic and
crude membrane fractions from PC12 cells revealed that
NECC2 protein is mostly distributed in the cytosol and, to a low
extent, associates with membrane fractions (Figure 4B). On the
other hand, exogenous cMyc-NECC2 containing the HR
domain was distributed in both fractions, with a higher content
in membrane fractions (Figure 4B). We next investigated the
type of association that NECC2 maintains with caveolae by
using a detergent-free method to isolate caveolae membranes
based in their “buoyant” properties [15]. As shown in Figure 4C,
endogenous NECC2 or NECC2ΔHR did not co-migrate with
caveolin-1 and TrkA to “buoyant” fractions. However, the
NECC2 isoform containing the HR separated with TrkA and
caveolin-1 in the gradient (Figure 4C). These results, together
with the microscopic data, suggest that the HR domain is
responsible for the integral association of NECC2 to caveolae
membranes, although NECC2 may also interact with caveolae
components as a peripheral protein.
NGF regulates NECC2 expression and distribution in
PC12 cells
The intracellular distribution of NECC2 during NGF-induced
PC12 cell differentiation was also investigated. Short-term
treatment of PC12 cells with NGF (0-120 min) increased the
association of NECC2 to the cell surface (Figure 5A).
Specifically, the percentage of cells with increased surface-
associated NECC2 immunoreactivity augmented from 50 to
66.0% after a 1-h exposure to NGF. Immunolabeling of NECC2
and exogenous HA-TrkA demonstrated that these proteins
colocalized at the cell surface of PC12 cells under basal
conditions (MC between NECC2 and TrkA was 0.187).
Colocalization between NECC2 and TrkA was transiently
decreased by 5 min and subsequently increased at later points
after short-term stimulation with NGF (MC = 0.092, 0.343,
0.603, and 0.564 at 5, 30, 60, and 120 min of NGF stimulation,
respectively). NECC2 immunoreactivity at the cell surface was
maintained in PC12 cells after long-term exposure to NGF (1-4
days) (Figure 5B). Along with this distribution, NECC2
immunosignal also localized to puncta/vesicular-like structures
in growing neurites and tips (Figure 5B), wherein it colocalized
with caveolin-1 (Figure 5C).
In line with the microscopic data, immunoblot analysis
revealed that NECC2 protein levels increased progressively
during NGF-induced differentiation of PC12 cells (Figure 5D).
NECC2 regulates NGF-mediated TrkA signaling
Given the NGF-dependent colocalization of NECC2 and
TrkA, we examined the effects of Necc2 silencing and
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Figure 2.  Intracellular distribution of endogenous NECC2 in PC12 cells.  A. Representative confocal images of a PC12 cell
immunolabeled with the anti-NECC2 antiserum. NECC2 distributes throughout the cytoplasm and in close apposition to the cell
membrane. Specificity of the signal was tested by preadsorption of the anti-NECC2 antibody with excess of antigen. B. PC12 cells
were double-stained with antibodies against NECC2 (red) and caveolin-1 or actin (green) (top and bottom panels respectively).
Significant overlap between markers at the cell periphery is shown in the binary mask at the rightmost panels. C. Prior to double
immunostaining with anti-NECC2 and anti-caveolin-1, PC12 cells were treated with 5 µmol/L of LatB for 30 min at 37°C. Scale bars,
10 µm.
doi: 10.1371/journal.pone.0073668.g002
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Figure 3.  Analysis of the intracellular localization of cMyc-tagged NECC2 variants.  A. Schematic representation of NECC2
constructs and its truncated variants lacking the hydrophobic region (NECC2ΔHR) or containing the first 4 N-terminal coiled-coil
regions (NECC2Δ372). B. Confocal images of PC12 cells co-expressing cMyc-NECC2 or its truncated forms and CFP-caveolin-1
(CFP-cav1). Full-length cMyc-NECC2 accumulates in the perinuclear area. NECC2ΔHR and NECC2Δ372 immunosignals
accumulate intracellularly and in the proximity of the cell surface. NECC2 immunofluorescence signal strongly overlaps with CFP-
caveolin-1 as shown in the binary mask (rightmost panel). Scale bars, 10 µm.
doi: 10.1371/journal.pone.0073668.g003
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Figure 4.  NECC2 associates to caveolae both as an integral membrane protein and a peripheral membrane protein.  A.
Immunoblot analysis of whole cell lysates from PC12 cells with the anti-NECC2 antibody. As control, anti-NECC2 antibody was pre-
incubated with an excess of antigen. B. Cytosolic (S) and crude membrane (P) fractions from PC12 cells were obtained by
subcellular fractionation as described in Methods and subsequent analyzed by immunoblotting. As shown by anti-NECC2 antibody
immunolabeling, NECC2 distributes in the cytosol and, to a lesser extent, it also associates with membrane fractions. In contrast,
exogenous full-length cMyc-NECC2 distributed to both fractions, with a higher content in the membrane fraction. The distribution of
EEA1, TrkA, GM130, actin and caveolin-1 was also analyzed. C. Caveolae-enriched membranes from PC12 cells were isolated by
using a detergent-free method based in a discontinuous sucrose gradient (5-35-45%). Distribution of endogenous NECC2 and
cMyc-tagged NECC2 variants were assayed by immunoblot. Neither NECC2 nor NECC2ΔHR co-migrated with caveolin-1 and TrkA
to the buoyant fraction (fraction 2).
doi: 10.1371/journal.pone.0073668.g004
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Figure 5.  NECC2 expression and distribution are regulated
by NGF.  A. Representative confocal images of HA-TrkA
transfected PC12 cells under basal conditions or treated with
NGF at the indicated time points. After treatment, cells were
subjected to double-immunofluorescence using anti-NECC2
and anti-HA antibodies. The colocalization channel was
isolated using Imaris 6.4 (Bitplane) and shown alone in the
images on the far bottom. Mander’s coefficient A (between
NECC2 and TkA) was calculated to quantify the degree of
colocalization and represented as the mean ±SEM of at least 5
cells per experimental group. a, P < 0.05 vs. control; b, P <
0.05 vs. 5 min; c, P < 0.05 vs. 30 min (unpaired, 2-tailed t test).
B. Representative micrographs of PC12 cells immunolabeled
with anti-NECC2 during long-term (1-4 days) stimulation with
NGF. NECC2 staining localizes beneath the plasma membrane
as well as in puncta/vesicular-like structures in growing
neurites and tips. C. Double-immunostaining of NGF-
differentiated PC12 cells with anti-NECC2 and anti-caveolin-1
sera. Scale bars, 10 µm. D. Protein extracts from NGF-
stimulated PC12 cells during differentiation (1-4 days) were
analyzed by immunoblotting using the anti-NECC2 antibody.
Quantitative data were represented as ratio of NECC2 vs.
Ponceau. The data represent the mean (± SEM) of three
independent experiments. a, P < 0.05 vs. corresponding
control; b, P < 0.05 vs. 1- or 2-days treated cells (one-way
ANOVA followed by Newman–Keuls test).
doi: 10.1371/journal.pone.0073668.g005
overexpression on the phosphorylation rate of the main TrkA-
activated effectors, ERK1/2 and Akt, in NGF-treated cells. To
reduce NECC2 expression, PC12 cells were stably transfected
with an expression vector encoding a shRNA for Necc2
(siRNA) (Figure 6A). Down-regulation of NECC2 expression
had no effect on cell viability as determined by the MTT assay
(0,1693 ± 0.0546 in mock-transfected cells vs. 0,1582 ± 0.0197
in Necc2 siRNA-expressing cells). Decreased concentrations of
NECC2 did not affect Akt phosphorylation at any time point
analyzed (Figure 6B). In contrast, phosphorylation of ERK1/2
was decreased in cells with reduced expression of NECC2.
Specifically, ERK phosphorylation ratio was numerically lower
in silenced cells than in mock-transfected cells at all the time
points tested, although differences between the two groups
reached statistical significance after 60 and 120 min of
exposure to NGF.
Finally, we examined the effect of NECC2 overexpression on
the phosphorylation of Akt and ERK1/2. To this end, PC12 cells
were transfected with the NECC2 isoform lacking the HR
domain, which colocalizes with TrkA, both at the cell surface
and intracellularly (Figure 7A), or with the long NECC2 isoform.
Overexpression of NECC2 had no effect on cell viability (data
not shown). Similar to that found in the silencing experiments,
increased expression of NECC2 or NECC2ΔHR did not modify
NGF-induced Akt phosphorylation (Figure 7B and 7C,
respectively). Up-regulation of NECC2 expression significantly
decreased NGF-activated ERK1/2 phosphorylation at 30, 60,
and 120 min of exposure to the neurotrophin (Figure 7D and
7E).
Discussion
Caveolae are cholesterol- and sphingolipid-rich membrane
microdomains, which, among other key functions, constitute
specialized signaling platforms that allow physical localization
and direct interaction of multiple types of receptors with their
intracellular mediators [28]. These specialized domains cluster
a variety of specific proteins, including the structural proteins
caveolins and cavins, along with several cytoskeletal proteins
and scaffolding factors which are essential for caveolae
formation, maintenance, and functional organization
[12,13,29–31].
Fluorescence microscopy using two different anti-NECC2
antibodies revealed that NECC2 co-localized with caveolin-1 at
the cell surface of PC12 cells. NECC2 immunosignal was also
closely associated with cortical actin, which has been shown to
regulate the dynamics and localization of caveolin-1 in
caveolae [32]. Accordingly, disruption of actin filaments by LatB
treatment altered NECC2 distribution and decreased
significantly the co-localization between NECC2 and both
caveolin-1 and actin. In all, these observations indicated that
NECC2 locates to caveolae in PC12 cells. These results were
in line with our in silico analysis showing the presence of two
CBD domains as well as four CRAC motifs in NECC2
sequence, which have been proposed to promote the
incorporation of proteins into cholesterol-rich domains [21,33].
Nevertheless, recent data indicates that CBDs are not enriched
among caveolin-binding proteins and, more importantly, that
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the interaction between CBDs and the scaffolding domain in
caveolin-1 does not likely mediate caveolae-associated
signaling [34]. In fact, our microscopy studies using truncated
NECC2 variants support the notion that neither the CBDs nor
the CRAC domains are required for the localization of NECC2
to caveolae. Alternatively, NECC2 targeting to caveolae might
occur via the interaction of its coiled-coil domains with
caveolae-resident proteins. In this regard, a role for coiled-coil
domains in intracellular targeting has been reported for the long
coiled-coil proteins associated to the Golgi apparatus, golgins
[11].
Subcellular fractionation studies showed that endogenous
NECC2 distributed mainly in the cytosol and, to a lesser extent,
in membrane fractions. Detergent-free extraction of caveolae-
enriched membranes and sucrose gradient fractionation
analysis confirmed that both the endogenous protein and the
NECC2 variant lacking the HR were located in non-buoyant
fractions. However, full-length NECC2 containing the HR
migrated to caveolae-enriched membrane fractions. These
observations, which are consistent with the expression of
several NECC2 variants in PC12 cells, suggest that NECC2
associates to caveolae membranes as an integral or a
peripheral membrane protein depending on the presence or
absence of the HR domain, respectively. In line with these
findings, the family of long coiled-coil proteins ERC comprises
two distinct members generated by alternative splicing, ERC1a
and ERC1b, that differ in both their expression pattern and
intracellular distribution [35]. Thus, whereas ERC1a is a
cytosolic protein, ERC1b is both a cytosolic protein and an
insoluble component of the active zone at the synapse [35].
Interestingly, golgins undergo disassociation/association cycles
between the cytosol and Golgi membranes [36]. Likewise, it
has been shown that soluble cavin proteins peripherally attach
to caveolae once they reach the cell surface [29]. In this
scenario, the NECC2 isoform lacking the HR might cycle
between a soluble, cytosolic pool and the caveolae membrane,
likely via its interaction with a caveolae-associated protein.
Neurotrophic factor receptors have been found associated
with lipid rafts in several cell types [16,37–40]. It has been
shown that TrkA receptor accumulation in lipid rafts facilitates
receptor dimerization and transphosphorylation [16,41]. Herein,
we observed that NECC2 colocalized at the cell surface with
the TrkA receptor, which has been located to caveolae in PC12
cells [15] (our unpublished observations). However, the extent
of colocalization between NECC2 and TrkA varied in a time-
dependent manner following NGF stimulation. Thus, this
colocalization transiently decreased by 5 minutes of NGF
stimulation, likely due to NGF-induced TrkA internalization, and
increased subsequently to reach a maximum after 60 minutes
of exposure to NGF. In line with this, it has been shown that,
following NGF-evoked internalization, TrkA receptors are
recycled back to the plasma membrane [42]. We observed that
both the percentage of PC12 cells showing accumulated
NECC2 at the plasma membrane and the amount of NECC2
immunosignal at the cell surface increased upon NGF
exposure, suggesting that this factor induces the recruitment of
NECC2 to cell surface microdomains. Similar results have
been reported for the adaptor protein that is responsible of
Figure 6.  Reduction of endogenous NECC2 by RNA interference impairs NGF-mediated TrkA signaling.  A. PC12 cells were
stably transfected with pEGFP-shRNA or Necc2-shRNA plasmid (siRNA) and whole protein extracts were analyzed for
immunoblotting using anti-NECC2 antibody and anti-actin antibody. B and C. PC12 cells overexpressing pEGFP-RNAi (MOCK) or
Necc2-shRNA (R1) were grown to 90% confluence and exposed for 4 h to serum-low differentiation media before NGF stimulation
for the indicated time points. Cell lysates were subjected to immunoblot with Akt and phospho-Akt (pAkt) antibodies (B) or with ERK
and phospho-ERK (pERK) antibodies (C). Quantitative data were represented as ratio of pAkt vs. Akt or pERK vs. ERK,
respectively. The data represent the means (± SEM) of three independent experiments. P < 0.05 vs. corresponding control
(unpaired, 2-tailed t test).
doi: 10.1371/journal.pone.0073668.g006
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Figure 7.  Overexpression of NECC2 inhibits NGF-mediated TrkA signaling pathway.  A. Representative confocal images of
PC12 cells transfected with cMyc-Necc2ΔHR and double-stained with anti-cMyc and anti-TrkA antibodies. Immunofluorescent
signals significantly overlap at the cell periphery and intracellularly as shown in the binary mask (right panels). Scale bars, 10 µm. B,
C, D and E. PC12 cells transiently transfected with full-length cMyc-Necc2, cMyc-Necc2ΔHR, or the empty vector (mock) were
grown to 90% confluence and exposed for 4 h to serum-low differentiation media before NGF stimulation for the indicated time
points. Whole cell protein extracts were then subjected to immunoblot with Akt and phospho-Akt (pAkt) antibodies (B and C) or with
ERK and phosphor-ERK (pERK) antibodies (D and E). Quantitative data were represented as ratio of pAkt vs. Akt or pERK vs. ERK,
respectively. The data represent the means (± SEM) of three independent experiments. P < 0.05 vs. corresponding control
(unpaired, 2-tailed t test).
doi: 10.1371/journal.pone.0073668.g007
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TrkA localization to lipid rafts, c-Cbl associated protein (CAP),
which also moves to the cell surface following short-term NGF
stimulation of PC12 cells [41].
Our microscopic and biochemical findings suggested that
NECC2 might regulate TrkA-mediated NGF signaling in
caveolae. In support of this proposal are our functional studies
showing that decreasing NECC2 content by shRNA-mediated
(siRNA) silencing altered NGF-induced phosphorylation of the
TrkA downstream effector ERK1/2. Remarkably, NECC2
silencing had no effect on NGF-induced activation of Akt, which
is also mediated via NGF binding to TrkA [43,44].
Overexpression of NECC2 mimicked the effects evoked by
NECC2 silencing on both signaling routes. When viewed
together, these data suggest that appropriate expression levels
of NECC2 are required for proper TrkA activity and strongly
support a role for this protein in the regulation of caveolae
function. In addition, they suggest that, when overexpressed,
NECC2 may display a dominant-negative effect, as it has been
previously reported for other long coiled-coil proteins [45].
Notably, it has been shown that overexpression of caveolin-1
functions as a dominant negative [26] and impairs NGF-
induced differentiation of PC12 cells [46].
Trafficking, sorting, and ubiquitination of ligand-activated
TrkA receptors regulate the magnitude and duration of the
intracellular response evoked by NGF [42]. It is well
established that TrkA activation triggers a transient, short-term
response (5 min) that involves the activation of both the
PI3K/Akt and the ERK/MAPK pathways [44]. Once in
endosomes, TrkA induces the selective activation of ERKs via
the small GTPase Rap1 and B-Raf [44,47]. In our study, we
observed that changes in NECC2 expression levels impaired
sustained ERK1/2 phosphorylation in response to NGF
treatment, without affecting NGF-induced Akt activation. Similar
results have been depicted for several TrkA-related signaling
adapter proteins located to lipid rafts, such as FRS2 and
ARMS/kidins220 [48–51]. In particular, both FRS2 and ARMS/
kidins220 are involved in the formation of the signalling
complex Crk-C3G, which is responsible of targeting NGF
signaling to Rap1-ERKs [48–50]. Crk possesses SH3 and SH2
domains, which are essential for its interaction with ARMS/
kidins220 and FRS2 [51,52]. Interestingly, NECC2 possesses a
proline-rich motif (PXXP), which is considered a target domain
for proteins containing SH3-type motifs [25]. Given this and the
structural features conferred by the coiled-coil domains [7],
together with our functional data, it is tempting to speculate that
NECC2 might act as a scaffolding factor facilitating the
interaction of the signaling molecules responsible of NGF-
dependent persistent ERK activation. Alternatively, NECC2
could play a role in TrkA compartmentalization and/or
trafficking towards the endosomal system by acting as a
tethering factor. In line with this proposal, golgins have been
shown to facilitate sorting and membrane trafficking across the
Golgi apparatus by regulating membrane-membrane and
membrane-cytoskeleton tethering events [11,53,54]. Likewise,
the long coiled-coil proteins liprins and ERC2/CAST, which are
located to the cytomatrix at the active zone of synapses, act as
regulators of membrane fusion events and stabilize these
membrane microdomains [9,10,55,56]. Interestingly, NECC2
distributed in neurites and growth cones in differentiated PC12
cells, wherein it largely colocalized with caveolin-1. It has been
reported that caveolin-1 recruits synaptic components and
regulates signal transduction of a variety of neurotransmitter
and neurotrophic receptors in the CNS [57], thus suggesting its
participation in synapse maturation and/or remodelation
[58–60]. In this scenario, a general role for NECC2 as
organizer of membrane microdomains specialized in signal
transduction seems plausible.
In sum, our data are the first to demonstrate the presence of
a long coiled-coil protein, NECC2, in caveolae, and to identify a
potential regulatory role for this protein in the control of the
NGF-TrkA system in PC12 cells.
Supporting Information
Figure S1.  Associated with Figure 2. Analysis of the
specificity of anti-NECC2 and anti-NECC2-II antibodies by
immunostainig. A. HEK293 AD cells were transfected with full-
length cMyc-Necc2 or cMyc-Necc1 and doubled-stained with
anti-cMyc (green) and anti-NECC2 antibodies (red). As shown
in the binary mask (right panels), the anti-NECC2 antibody
recognized exogenous NECC2, but not NECC1. Scale bars, 10
µm B. PC12 cells were immunolabeled with anti-NECC2-II
(red) and anti-caveolin1 (green) antibodies. NECC2 distributes
at the plasma membrane (left panel). Significant colocalization
between NECC2 and caveolin-1 (green) is shown in the binary
mask at the rightmost panels. C. cMyc-Necc2- or cMyc-Necc1-
transfected HEK293 AD cells were immunolabeled with anti-
cMyc (green) and anti-NECC2-II (red) antibodies. Anti-NECC2-
II antibody recognized exogenous NECC2 but not NECC1. D.
Immunoblot analysis of PC12 cell lysates using the anti-NECC-
II antibody revealed a 110-kDa immunoreactive band along
with two other bands of 140 and 95 kDa.
(TIF)
Figure S2.  Associated with Figure 3. Intracellular distribution
of exogenous NECC2 and Caveolin1. A. PC12 were
transfected with cMyc-Necc2, GFP-Necc2, or untagged Necc2
and stained with anti-cMyc (leftmost panel) or anti-NECC2
antibodies (rightmost panel). Regardless of the reporter
sequence used, NECC2 exhibited a juxtanuclear distribution in
transfected PC12 cells. B. Representative confocal images of
PC12 cells transfected with CFP-Caveolin-1 (GFP-cav1). CFP-
cav1 located to the plasma membrane and also accumulated
close to the nucleus, as has been previously reported for other
cell types [26,27]. Scale bars, 10 µm.
(TIF)
Figure S3.  Associated with Figure 4. Analysis of the
specificity of anti-NECC2 and anti-NECC2-II antibodies by
immunoblotting. A. HEK293 AD cells were transfected with
cMyc-Necc2 or cMyc-Necc1 and analyzed by immunoblotting
using anti-cMyc, anti-NECC2, and anti-NECC2-II antibodies.
Non-transfected HEK293 AD cells were used as controls.
Exogenous NECC2 protein, but not NECC1, was detected with
the anti-NECC2 and the anti-NECC-II antibodies. B.
Immunoblot analysis of whole cell lysates from cMyc-Necc1- or
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cMyc-Necc2Δ285- transfected HEK293 AD cells. Anti-NECC-II
antibody did not recognize cMyc-Necc2Δ285, the truncated
form of NECC2 lacking the peptide sequence employed to
obtain the anti-NECC2-II antibody. C. HEK293 AD cells were
transfected with cMyc-Necc2Δ285 and double-stained with
anti-cMyc (green) and anti-NECC2 antibodies (red). As shown
in the images, anti-NECC2-II antibody did not recognize the
truncated form, cMyc-NECC2Δ285. Scale bars, 10 µm.
(TIF)
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